RS

Ravi Savarirayan

Immuron Limited | Non-Executive Director
Mr Savarirayan has been a consultant clinical geneticist at the Victorian Clinical Genetics Services since August 1999, as well as professor and research group leader of Molecular therapies at the Murdoch Children's Research Institute since September 2000. Prof. Savarirayan has served as a founding member of the Skeletal Dysplasia Management Consortium since January 2011 and has acted as the chair of the specialist advisory committee in clinical genetics at the Royal Australasian College of Physicians since February 2009. He was president of the International Skeletal Dysplasia Society from July 2009 to June 2011 and has been an invited member of several international working committees on constitutional diseases of bone. Prof. Savarirayan's primary research focus is on inherited disorders of the skeleton causing short stature, arthritis and osteoporosis. He has published over 210 peer-reviewed articles, collaborating with peers from over 30 countries. He has been on the editorial board of Human Mutation since January 2009, European Journal of Human Genetics since July 2007, American Journal of Medical Genetics since December 2011 and the Journal of Medical Genetics since June 2005. He is an NHMRC Leadership fellow.

Company and Role

Company
Title
Tenure
Since
IMC
Immuron Limited
  • Non-Executive Director
7yrs, 3mthApr 2017

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMC
Immuron Limited
30/06/23409,090468,750900,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMC
Immuron Limited
09/02/21
Exercise
900,000$0.230$207,000Exercise of options
IMC
Immuron Limited
09/02/21
Buy
409,090$0.230$94,090Exercise of options
IMC
Immuron Limited
13/11/20
Issued
468,750$0.080$37,500Issue of securities
IMC
Immuron Limited
13/11/20
Issued
1,800,000$0.255$459,000Issue of securities
IMC
Immuron Limited
23/06/17
Issued
1,000,000$0.315$315,000Issue of options. As per announcement on 03/07/2017.